Linda S. Klavinskis - Concepedia

Author

Linda S. Klavinskis

Also Known As

L Klavinskis, L S KLAVINSKIS, L S Klavinskis, L. Klavinskis, L. S. Klavinskis, L.S. Klavinskis, LINDA S. KLAVINSKIS, Linda Klavinskis, Linda S Klavinskis, Linda S. Klavinskis

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

King's College London Guy's Hospital Scripps Health St Thomas' Hospital Scripps Clinic

About

Linda S. Klavinskis is an author at King's College London specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	1.4K
2	Immunology	18	19	1.3K
3	Cell Biology	5	5	252
4	Allergy	3	3	312
5	Microbiology	1	1	105

Linda S. Klavinskis

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques Thomas Lehner, Yufei Wang, Martin Cranage, Nature Medicine	1996	294
TCR contact residue hydrophobicity is a hallmark of immunogenic CD8<sup>+</sup>T cell epitopes Diego Chowell, Sri Krishna, Pablo D. Becker, Proceedings of the National Academy of Sciences	2015	241
Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 Adel Benlahrech, Julian D. Harris, Andrea Meiser, Proceedings of the National Academy of Sciences	2009	142
Induction of Mucosal and Systemic Immunity to a Recombinant Simian Immunodeficiency Viral Protein Thomas Lehner, Lesley A. Bergmeier, C Panagiotidi, Science	1992	141
Intranasal Immunization with Plasmid DNA-Lipid Complexes Elicits Mucosal Immunity in the Female Genital and Rectal Tracts Linda S. Klavinskis, Christina Barnfield, Liquan Gao, The Journal of Immunology ImmunologyPathologyAntigen ProcessingInnate ImmunityImmunotherapy	1999	133
Cutting Edge: CD8+ T Cell Priming in the Absence of NK Cells Leads to Enhanced Memory Responses Katrina Soderquest, Thierry Walzer, Biljana Zafirova, The Journal of Immunology	2011	132
Vaccination and protection from a lethal viral infection: Identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope Linda S. Klavinskis, J. Lindsay Whitton, Etienne Joly, Virology VaccinationMucosal VaccinationVaccine DevelopmentVaccine ResearchVaccine Target	1990	131
Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection Linda S. Klavinskis, J. Lindsay Whitton, Michael B. A. Oldstone Journal of Virology VaccinationMucosal VaccinationVaccine DevelopmentCtl VaccineVaccine Target	1989	126
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity Barry Peters, Walter Jaoko, Eftyhia Vardas, Vaccine VaccinationVaccine DevelopmentImmunologyVirologyHiv	2006	109
<i>Bacillus subtilis</i> spores: A novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen Andrew G. C. Barnes, Vuk Cerovic, Philip Hobson, European Journal of Immunology Microbial PathogensHumoral ResponseImmunologyBacteriologyImmunodominance	2007	105

Page 1